Norway made its first family planning commitment in 2012, pledging to double its investment in family planning from US$25 million to US$50 million over eight years. In 2017, Norway renewed its commitment, pledging to increase its core contribution to UNFPA by 25 percent, up to NOK500 million per year. To expand access to quality reproductive commodities for women in the poorest countries, Norway committed to providing an additional NOK50 million in direct support to UNFPA Supplies; supporting civil society organizations engaged in SRHR and safe abortion with approximately NOK409 million up to 2020; and expanding comprehensive sexual education to protect the health and well-being of adolescents, and enable them to make good life choices. Additionally, they pledged to increase investments for sexual and reproductive health rights by approximately NOK700 mill in 2017-2020.
Norway FP2020 Commitment
Donor Government Assistance for Family Planning in 2013
Donor Government Assistance for Family Planning in 2014
Norway FP2020 Commitment Self-reporting Questionnaire 2014
Funding disbursed against the London Family Planning Summit commitment amount to US$25 million; US$13 million were channeled through UNFPA and further amounts were channeled through MSI and PSI to scale up access to contraceptive implants (US$5 million).
Donor Government Assistance for Family Planning in 2015
Norway Revitalized FP2020 Commitment
Implant Access Program: Expanding Family Planning Options for Women
A group of public and private organizations, including the government of Norway, have collaborated to make Bayer’s Jadelle® and MSD’s Implanon NXT® available to women in the world’s poorest countries at price reductions of approximately 50% through 2018 (price reductions subsequently extended to 2023).